Alaunos Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2010 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Alaunos Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2010 to Q1 2025.
  • Alaunos Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 31, 2025 was 1.6M shares, a 90% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 1.6M -14.4M -90% Mar 31, 2025 10-K 2025-03-31
Q3 2024 1.6M -239M -99.3% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 1.6M -239M -99.3% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 16M -225M -93.3% Mar 27, 2024 10-K 2024-04-01
Q3 2023 241M +24.4M +11.3% Nov 9, 2023 10-Q 2023-11-14
Q2 2023 241M +24.5M +11.3% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 241M +24.5M +11.3% Mar 2, 2023 10-K 2023-03-07
Q3 2022 216M +36.2K +0.02% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 216M +615K +0.29% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 216M +602K +0.28% Mar 21, 2022 10-K 2022-03-30
Q3 2021 216M +1.85M +0.87% Oct 29, 2021 10-Q 2021-11-08
Q2 2021 216M +1.41M +0.66% Jul 31, 2021 10-Q 2021-08-13
Q1 2021 216M +1.24M +0.58% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 214M +33.3M +18.4% Oct 29, 2020 10-Q 2020-11-05
Q2 2020 214M +51.6M +31.7% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 214M +51.9M +32% Apr 24, 2020 10-Q 2020-05-07
Q4 2019 213M Feb 14, 2020 10-K 2020-03-02
Q3 2019 181M +38.7M +27.1% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 163M +20.2M +14.2% Jul 24, 2019 10-Q 2019-08-08
Q1 2019 162M +20M +14% Apr 30, 2019 10-Q 2019-05-08
Q3 2018 142M +417K +0.29% Oct 31, 2018 10-Q 2018-11-09
Q2 2018 142M +417K +0.29% Jul 24, 2018 10-Q 2018-08-08
Q1 2018 142M +10M +7.57% Apr 24, 2018 10-Q 2018-05-10
Q3 2017 142M +10.2M +7.77% Oct 31, 2017 10-Q 2017-11-06
Q2 2017 142M +10.2M +7.77% Jul 24, 2017 10-Q 2017-07-31
Q1 2017 132M +541K +0.41% Apr 24, 2017 10-Q 2017-05-01
Q4 2016 132M +658K +0.5% Feb 6, 2017 10-K 2017-02-16
Q3 2016 132M +844K +0.64% Nov 3, 2016 10-Q 2016-11-09
Q2 2016 132M +880K +0.67% Aug 9, 2016 10-Q 2016-08-09
Q1 2016 132M +3.61M +2.81% Apr 26, 2016 10-Q 2016-05-10
Q4 2015 132M +17M +14.8% Feb 10, 2016 10-K 2016-02-24
Q3 2015 131M +28.2M +27.4% Oct 26, 2015 10-Q 2015-11-02
Q2 2015 131M +30.1M +29.9% Jul 25, 2015 10-Q 2015-08-10
Q1 2015 128M +27.5M +27.3% May 1, 2015 10-Q 2015-05-07
Q4 2014 115M +14.1M +14.1% Feb 10, 2015 10-K 2015-02-26
Q3 2014 103M +19M +22.7% Oct 30, 2014 10-Q 2014-10-30
Q2 2014 101M +17.2M +20.6% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 101M +17.2M +20.5% Apr 30, 2014 10-Q 2014-05-08
Q4 2013 101M Feb 10, 2014 10-K 2014-03-03
Q3 2013 83.7M +4.08M +5.12% Oct 14, 2013 10-Q 2013-10-22
Q2 2013 83.5M +3.95M +4.97% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 83.6M +4.04M +5.08% May 1, 2013 10-Q 2013-05-07
Q3 2012 79.6M +11.2M +16.3% Oct 26, 2012 10-Q 2012-11-08
Q2 2012 79.6M +11.2M +16.3% Jul 29, 2012 10-Q/A 2012-08-28
Q1 2012 79.5M Apr 23, 2012 10-Q 2012-05-03
Q3 2011 68.5M +19.9M +41% Oct 28, 2011 10-Q 2011-11-03
Q2 2011 68.4M Jul 27, 2011 10-Q/A 2011-08-09
Q3 2010 48.6M Nov 1, 2010 10-Q 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.